Form 4 for ONC BeOne Medicines Ltd.
Accepted 2022-03-02 00:00:00 ET · period of report 2022-02-28 · accession 0001651308-22-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-02 | 2022-02-28 | ONC | Wang Julia Aijun | CFO | A - Grant | $0.00 | +61.8K | 143.3K | +76% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-02-28 | A | A | 61,750 | $0.00 | 143,299 | D | — | — | (F1) Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of February 28, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control. (F2) Includes 1,677 ordinary shares acquired pursuant to the Company's Second Amended and Restated 2018 Employee Share Purchase Plan. |